Vivani Medical Inc. (VANI)
Vivani Medical Statistics
Share Statistics
Vivani Medical has 59.24M shares outstanding. The number of shares has increased by 7.74% in one year.
| Shares Outstanding | 59.24M |
| Shares Change (YoY) | 7.74% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 8.78% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 52 |
| FTD / Avg. Volume | 0.06% |
Short Selling Information
The latest short interest is 348.23K, so 0.52% of the outstanding shares have been sold short.
| Short Interest | 348.23K |
| Short % of Shares Out | 0.52% |
| Short % of Float | 0.84% |
| Short Ratio (days to cover) | 2.83 |
Valuation Ratios
The PE ratio is -2.72 and the forward PE ratio is -2.02. Vivani Medical's PEG ratio is 0.19.
| PE Ratio | -2.72 |
| Forward PE | -2.02 |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 3.62 |
| P/FCF Ratio | -2.99 |
| PEG Ratio | 0.19 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Vivani Medical.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.41, with a Debt / Equity ratio of 1.1.
| Current Ratio | 3.41 |
| Quick Ratio | 3.41 |
| Debt / Equity | 1.1 |
| Debt / EBITDA | -0.78 |
| Debt / FCF | -0.9 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-634,756.76 |
| Employee Count | 37 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -39.53% in the last 52 weeks. The beta is 3.32, so Vivani Medical's price volatility has been higher than the market average.
| Beta | 3.32 |
| 52-Week Price Change | -39.53% |
| 50-Day Moving Average | 1.07 |
| 200-Day Moving Average | 1.2 |
| Relative Strength Index (RSI) | 48.53 |
| Average Volume (20 Days) | 90,780 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -24.68M |
| Net Income | -23.49M |
| EBITDA | -24.68M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.43 |
Balance Sheet
The company has 18.35M in cash and 19.31M in debt, giving a net cash position of -961K.
| Cash & Cash Equivalents | 18.35M |
| Total Debt | 19.31M |
| Net Cash | -961K |
| Retained Earnings | -121.92M |
| Total Assets | 41.56M |
| Working Capital | 14.46M |
Cash Flow
In the last 12 months, operating cash flow was -20.79M and capital expenditures -556K, giving a free cash flow of -21.34M.
| Operating Cash Flow | -20.79M |
| Capital Expenditures | -556K |
| Free Cash Flow | -21.34M |
| FCF Per Share | -0.39 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VANI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for VANI is $4, which is 284.6% higher than the current price. The consensus rating is "Buy".
| Price Target | $4 |
| Price Target Difference | 284.6% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Aug 19, 2022. It was a backward split with a ratio of 1:3.
| Last Split Date | Aug 19, 2022 |
| Split Type | backward |
| Split Ratio | 1:3 |
Scores
| Altman Z-Score | -4.09 |
| Piotroski F-Score | 2 |